Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory

被引:123
作者
Philip, J
Smith, WB
Craft, P
Lickiss, N
机构
[1] Alfred Hosp, Palliat Care Dept, Prahran, Vic 3181, Australia
[2] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia
[3] Canberra Hosp, Canberra, ACT, Australia
[4] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia
关键词
symptom assessment; symptom measurement; cancer pain; ESAS;
D O I
10.1007/s005200050212
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As part of a longitudinal prospective study we sought a self-completed instrument of symptom assessment suitable for a population of cancer patients who were receiving palliative therapy. The modified Edmonton Symptom Assessment System (ESAS) is such an instrument, but it required validation for this population. This study represents a validation of the modified ESAS with the Rotterdam Symptom Checklist and the Brief Pain Inventory - two instruments widely used in patients receiving palliative therapy for cancer. We conclude that the modified ESAS is a valid, self-administered instrument to assess symptoms for patients from differing palliative care settings.
引用
收藏
页码:539 / 541
页数:3
相关论文
共 7 条
[1]  
Bruera E, 1991, J Palliat Care, V7, P6
[2]  
Bruera E., 1993, CLIN AUDIT PALLIATIV
[3]   DEVELOPMENT OF THE WISCONSIN BRIEF PAIN QUESTIONNAIRE TO ASSESS PAIN IN CANCER AND OTHER DISEASES [J].
DAUT, RL ;
CLEELAND, CS ;
FLANERY, RC .
PAIN, 1983, 17 (02) :197-210
[4]   MEASURING PSYCHOLOGICAL AND PHYSICAL DISTRESS IN CANCER-PATIENTS - STRUCTURE AND APPLICATION OF THE ROTTERDAM-SYMPTOM-CHECKLIST [J].
DEHAES, JCJM ;
VANKNIPPENBERG, FCE ;
NEIJT, JP .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :1034-1038
[5]   CORRELATION OF PATIENT AND CAREGIVER RATINGS OF CANCER PAIN [J].
GROSSMAN, SA ;
SHEIDLER, VR ;
SWEDEEN, K ;
MUCENSKI, J ;
PIANTADOSI, S .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1991, 6 (02) :53-57
[6]  
Rathbone G. V., 1994, Palliative Medicine, V8, P29, DOI 10.1177/026921639400800105
[7]   Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points [J].
Tannock, IF ;
Osoba, D ;
Stockler, MR ;
Ernst, DS ;
Neville, AJ ;
Moore, MJ ;
Armitage, GR ;
Wilson, JJ ;
Venner, PM ;
Coppin, CML ;
Murphy, KC .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1756-1764